Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Influenza, Human × baloxavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Influenza, Human 1 Hematologic Neoplasms 1

Interventions

Influenza Vaccines 5 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 thymoglobulin 1 fludarabine 1 baloxavir 1 Rituximab 1 Oseltamivir 1 Nivolumab 1 Melphalan 1 Levetiracetam 1 Ipilimumab 1 Fluzone High-Dose 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04712539 2026-02-11

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

M.D. Anderson Cancer Center

Phase 2 Recruiting

Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡